SCHEMBL22722669

SCHEMBL22722669

c1ccc(-c2cccc(-c3nc(-c4cccc(-c5ccccc5)c4)nc(-c4cccc(-c5cc(-c6ccccc6)c(-c6ccccc6)c(-c6ccccc6)c5-c5ccccc5)c4)n3)c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GP6 Q9HCN6 1/20 0.42
KMO O15229 1/20 0.39
MEN1 O00255 3/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPT P10636 3/20 0.39
HPGD P15428 3/20 0.39
KMT2A Q03164 3/20 0.39
KDM4E B2RXH2 2/20 0.39
LMNA P02545 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
GLA P06280 1/20 0.36
MAOA P21397 1/20 0.35
FGFR1 P11362 1/20 0.35
DYRK3 O43781 1/20 0.35
CLK1 P49759 1/20 0.35
CLK2 P49760 1/20 0.35
CLK3 P49761 1/20 0.35
GSK3B P49841 1/20 0.35
CDK5 Q00535 1/20 0.35
DYRK1A Q13627 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20080971 0.98 L3MBTL1 (0.41) GP6KMOMEN1ALDH1A1MAPT
SCHEMBL19497364 0.98 L3MBTL1 (0.41) GP6KMOMEN1ALDH1A1MAPT
SCHEMBL20080954 0.98 L3MBTL1 (0.41) GP6KMOMEN1ALDH1A1MAPT
SCHEMBL31453997 0.98 L3MBTL1 (0.41) GP6KMOMEN1ALDH1A1MAPT
SCHEMBL20080976 0.97 MEN1 (0.42) GP6KMOMEN1ALDH1A1MAPT
SCHEMBL18180827 0.97 MEN1 (0.42) GP6KMOMEN1ALDH1A1MAPT
SCHEMBL20080924 0.97 MEN1 (0.42) GP6KMOMEN1ALDH1A1MAPT
SCHEMBL31624102 0.96 L3MBTL1 (0.42) GP6MEN1ALDH1A1MAPTHPGD
SCHEMBL29500541 0.96 L3MBTL1 (0.42) GP6MEN1ALDH1A1MAPTHPGD
SCHEMBL18180975 0.96 L3MBTL1 (0.42) GP6MEN1ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10851056-B2 Compound for organic optoelectronic device, organic optoelectronic device and display apparatus SAMSUNG SDI CO., LTD. (KR) 2020-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10851056-B2 Compound for organic optoelectronic device, organic optoelectronic device and display apparatus OXER1, OR10J3, AOX1 GP6 1179/4885KMO 671/4885MEN1 2402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.